Skip to main content
. 2017 Jul 1;24(7):643–659. doi: 10.5551/jat.39917

Fig. 5b.

Fig. 5b.

Subgroup analysis: WMD with 95% CI of CIMT in subjects with SCH at pre- to post-treatment with thyroxin.